An independent advisory committee for the Food and Drug Administration voted Thursday to recommendTrusted Source emergency approval of a COVID-19 vaccine developed by Pfizer and BioNTech. The FDA isn’t required to follow the advice of the Vaccines and Related Biological Products Advisory Committee, although it usually does. The panel voted to recommend approval with 17 votes for approval, four against and one abstaining. The committee’s recommendation is for emergency use of the vaccine in people 16 years or older. However, there was disagreement among the committee on whether 16- and 17-year-olds should be included, due to a lack of clinical trial data on this group. To read the full story.
- Microplastics: Small Particles, Big Problem?
- Rutgers Researchers Use Artificial Intelligence to Predict Cardiovascular Disease.
- Rutgers Office for Research Using Data to Inform and Improve the Rutgers Research Enterprise.
- Structural Racism and Public Health – AJPH Supplement
- NJACTS Community Engagement Core COVID-19 Resources
- News (1,660)